Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (Fc gamma RIIA): a new option in HIT?

Luise Goldmann; Rundan Duan; Thorsten Kragh; Georg Wittmann; Christian Weber; Reinhard Lorenz; Philipp von Hundelshausen; Michael Spannagl; Wolfgang Siess

doi:10.1182/bloodadvances.2019000617

Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (Fc gamma RIIA): a new option in HIT?

Luise Goldmann, Rundan Duan, Thorsten Kragh, Georg Wittmann, Christian Weber, Reinhard Lorenz, Philipp von Hundelshausen, Michael Spannagl, Wolfgang Siess^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	4021-4033
Number of pages	13
Journal	Blood advances
Volume	3
Issue number	23
DOIs	https://doi.org/10.1182/bloodadvances.2019000617
Publication status	Published - 10 Dec 2019

Keywords

MULTIPLE ELECTRODE AGGREGOMETRY
IBRUTINIB
PHOSPHORYLATION
POLYMORPHISM
AGGREGATION
THROMBOSIS
ACID
GPVI
TOOL
BTK

Access to Document

10.1182/bloodadvances.2019000617

Cite this

Goldmann, L., Duan, R., Kragh, T., Wittmann, G., Weber, C., Lorenz, R., von Hundelshausen, P., Spannagl, M., & Siess, W. (2019). Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (Fc gamma RIIA): a new option in HIT? Blood advances, 3(23), 4021-4033. https://doi.org/10.1182/bloodadvances.2019000617

@article{964526dde93d47cf91b88d7eff541336,

title = "Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (Fc gamma RIIA): a new option in HIT?",

keywords = "MULTIPLE ELECTRODE AGGREGOMETRY, IBRUTINIB, PHOSPHORYLATION, POLYMORPHISM, AGGREGATION, THROMBOSIS, ACID, GPVI, TOOL, BTK",

author = "Luise Goldmann and Rundan Duan and Thorsten Kragh and Georg Wittmann and Christian Weber and Reinhard Lorenz and {von Hundelshausen}, Philipp and Michael Spannagl and Wolfgang Siess",

year = "2019",

month = dec,

day = "10",

doi = "10.1182/bloodadvances.2019000617",

language = "English",

volume = "3",

pages = "4021--4033",

journal = "Blood advances",

issn = "2473-9529",

publisher = "The American Society of Hematology",

number = "23",

}

Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (Fc gamma RIIA) : a new option in HIT? / Goldmann, Luise; Duan, Rundan; Kragh, Thorsten; Wittmann, Georg; Weber, Christian; Lorenz, Reinhard; von Hundelshausen, Philipp; Spannagl, Michael; Siess, Wolfgang.

In: Blood advances, Vol. 3, No. 23, 10.12.2019, p. 4021-4033.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (Fc gamma RIIA)

T2 - a new option in HIT?

AU - Goldmann, Luise

AU - Duan, Rundan

AU - Kragh, Thorsten

AU - Wittmann, Georg

AU - Weber, Christian

AU - Lorenz, Reinhard

AU - von Hundelshausen, Philipp

AU - Spannagl, Michael

AU - Siess, Wolfgang

PY - 2019/12/10

Y1 - 2019/12/10

KW - MULTIPLE ELECTRODE AGGREGOMETRY

KW - IBRUTINIB

KW - PHOSPHORYLATION

KW - POLYMORPHISM

KW - AGGREGATION

KW - THROMBOSIS

KW - ACID

KW - GPVI

KW - TOOL

KW - BTK

U2 - 10.1182/bloodadvances.2019000617

DO - 10.1182/bloodadvances.2019000617

M3 - Article

VL - 3

SP - 4021

EP - 4033

JO - Blood advances

JF - Blood advances

SN - 2473-9529

IS - 23

ER -